Ondine Biomedical logo

Ondine Biomedical

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$11.5M


Ondine Biomedical specializes in developing light-activated antimicrobials for nasal decolonization to reduce hospital-associated infections.

Total Funding

$11.5M

Headquarters

Vancouver, Canada

Founded

N/A

Focus Areas

Light-activated antimicrobials
nasal decolonization
hospital-associated infections
Steriwave technology
Phase 3 trial
healthcare collaboration.

Investors

M&G Investment Management logo